These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9303962)

  • 21. [Thrombopenia under low molecular weight heparin after treatment with pentosan polyphosphate].
    Paille F; Boccaccini A; de Korwin JD; Schmidt C; Laprevote MC; Schmitt J; Royer RJ
    Therapie; 1988; 43(4):322-3. PubMed ID: 2460963
    [No Abstract]   [Full Text] [Related]  

  • 22. Progressive Maculopathy After Discontinuation of Pentosan Polysulfate Sodium.
    Huckfeldt RM; Vavvas DG
    Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):656-659. PubMed ID: 31671200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidural hematoma after epidural steroid injection: a possible association with use of pentosan polysulfate sodium.
    Siddiqui MN; Ranasinghe JS; Siddiqui S
    Anesthesiology; 2001 Nov; 95(5):1307. PubMed ID: 11685018
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase I trial of pentosan polysulfate.
    Swain SM; Parker B; Wellstein A; Lippman ME; Steakley C; DeLap R
    Invest New Drugs; 1995; 13(1):55-62. PubMed ID: 7499109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombocytopenia related to synthetic heparin analogue therapy.
    Gouault-Heilmann M; Payen D; Contant G; Intrator L; Huet Y; Schaeffer A
    Thromb Haemost; 1985 Aug; 54(2):557. PubMed ID: 2417357
    [No Abstract]   [Full Text] [Related]  

  • 26. Heparin-induced thrombocytopenia and pentosan polysulfate: treatment with a low molecular weight heparin despite in vitro platelet aggregation.
    Vitoux JF; Roncato M; Hourdebaigt P; Aiach M; Fiessinger JN
    Thromb Haemost; 1986 Apr; 55(2):294-5. PubMed ID: 2424119
    [No Abstract]   [Full Text] [Related]  

  • 27. Maculopathy caused by pentosan polysulfate.
    Rosenberg D; Sarraf D; Chaudhary V
    CMAJ; 2021 May; 193(18):E645. PubMed ID: 33941523
    [No Abstract]   [Full Text] [Related]  

  • 28. Large Subfoveal Vitelliform Lesions in a Case of Pentosan Polysulfate Maculopathy.
    Wannamaker KW; Sisk RA
    Ophthalmology; 2020 Dec; 127(12):1641. PubMed ID: 33222775
    [No Abstract]   [Full Text] [Related]  

  • 29. Misleading report of massive bleeding in a patient taking pentosan polysulfate.
    Parsons CL
    Arch Intern Med; 2003 Jan; 163(1):119; authors reply 119-20. PubMed ID: 12523927
    [No Abstract]   [Full Text] [Related]  

  • 30. Pentosan induced cerebral sagittal sinus thrombosis: a variant of heparin induced thrombocytopenia.
    Rice L; Kennedy D; Veach A
    J Urol; 1998 Dec; 160(6 Pt 1):2148. PubMed ID: 9817346
    [No Abstract]   [Full Text] [Related]  

  • 31. Perioperative Management of Patients Receiving Pentosan Polysulfate Sodium (Elmiron).
    Narouze S; Provenzano D; Rech GR
    Reg Anesth Pain Med; 2016; 41(5):658. PubMed ID: 27547908
    [No Abstract]   [Full Text] [Related]  

  • 32. Re: Review - Proctor JG. Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation?
    Foote J; Shiromani S; Jain N
    Can J Urol; 2024 Jun; 31(3):11867-11868. PubMed ID: 38912936
    [No Abstract]   [Full Text] [Related]  

  • 33. Re: Letter to the Editor - Proctor JG. Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation?
    Proctor JG
    Can J Urol; 2024 Jun; 31(3):11869-11870. PubMed ID: 38912937
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
    Modi NB; Kell S; Simon M; Vargas R
    J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pentosan polysulfate maculopathy versus age-related macular degeneration: comparative assessment with multimodal imaging.
    Christiansen JS; Barnes AC; Berry DE; Jain N
    Can J Ophthalmol; 2022 Feb; 57(1):16-22. PubMed ID: 33722504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pentosan Polysulfate-Associated Macular Disease in Patients With Interstitial Cystitis.
    Lyons RJ; Ahmad S; Ansari S; Foote JE; Jain N
    Obstet Gynecol; 2020 May; 135(5):1091-1094. PubMed ID: 32282604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of heparin-induced thrombocytopenia that worsened preexisting cerebral infarction].
    Yaguchi H; Mitsumura H; Ozawa R; Sato H; Inoue K
    Rinsho Shinkeigaku; 2004 Sep; 44(9):636-8. PubMed ID: 15515711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strength of Association between Pentosan Polysulfate and a Novel Maculopathy.
    Hanif AM; Shah R; Yan J; Varghese JS; Patel SA; Cribbs BE; O'Keefe G; Hendrick AM; Shantha JG; Hubbard GB; Patel PS; Rao P; Yeh S; Jain N
    Ophthalmology; 2019 Oct; 126(10):1464-1466. PubMed ID: 31004677
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperkalaemic paralysis.
    Jolobe OM
    Age Ageing; 2003 Sep; 32(5):556-7. PubMed ID: 12958012
    [No Abstract]   [Full Text] [Related]  

  • 40. Pentosan polysulphate associated thrombocytopenia.
    Follea G; Hamandjian I; Trzeciak MC; Nedey C; Streichenberger R; Dechavanne M
    Thromb Res; 1986 May; 42(3):413-8. PubMed ID: 2424121
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.